Common Stock, Shares, Outstanding of BRAINSTORM CELL THERAPEUTICS INC. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BRAINSTORM CELL THERAPEUTICS INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • BRAINSTORM CELL THERAPEUTICS INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 11,034,775, a 108% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

BRAINSTORM CELL THERAPEUTICS INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 11,034,775 +5,724,979 +108% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 10,120,109 -69,526,833 -87% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 7,911,204 -60,535,989 -88% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 6,141,762 +2,109,148 +52% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 5,309,796 -40,005,165 -88% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 79,646,942 +38,720,197 +95% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 68,447,193 +29,971,942 +78% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 4,032,614 -32,661,464 -89% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 45,314,961 +8,773,182 +24% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 40,926,745 +4,440,565 +12% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 38,475,251 +1,989,071 +5.5% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 36,694,078 +292,665 +0.8% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 36,541,779 +263,826 +0.73% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 36,486,180 +167,619 +0.46% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 36,486,180 +167,619 +0.46% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 36,401,413 +1,241,436 +3.5% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 36,277,953 +4,710,361 +15% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 36,318,561 +6,648,706 +22% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 36,318,561 +7,894,724 +28% 31 Mar 2021 10-Q 26 Apr 2021 2021 Q1
Q4 2020 35,159,977 +11,985,749 +52% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 31,567,592 +8,961,100 +40% 30 Sep 2020 10-Q 15 Oct 2020 2020 Q3
Q2 2020 29,669,855 +7,961,413 +37% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 28,423,837 +6,933,227 +32% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 23,174,228 +2,416,412 +12% 31 Dec 2019 10-K 04 Feb 2021 2020 FY
Q3 2019 22,606,492 +1,905,779 +9.2% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 21,708,442 +1,038,914 +5% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 21,490,610 +2,379,284 +12% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 20,757,816 +1,781,647 +9.4% 31 Dec 2018 10-K 18 Feb 2020 2019 FY
Q3 2018 20,700,713 +1,857,987 +9.9% 30 Sep 2018 10-Q 29 Oct 2018 2018 Q3
Q2 2018 20,669,528 +1,922,201 +10% 30 Jun 2018 10-Q 23 Jul 2018 2018 Q2
Q1 2018 19,111,326 +411,661 +2.2% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 18,976,169 +288,182 +1.5% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 18,842,726 +154,739 +0.83% 30 Sep 2017 10-Q 17 Oct 2017 2017 Q3
Q2 2017 18,747,327 +93,287 +0.5% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 18,699,665 +45,625 +0.24% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 18,687,987 +44,699 +0.24% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 18,687,987 +207,030 +1.1% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 18,654,040 +173,083 +0.94% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 18,654,040 +260,494 +1.4% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 18,643,288 +3,361,791 +22% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q3 2015 18,480,957 +3,252,793 +21% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 18,480,957 -206,991,661 -92% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 18,393,546 -158,410,041 -90% 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 15,281,497 +3,530,616 +30% 31 Dec 2014 10-K 09 Mar 2016 2015 FY
Q3 2014 15,228,164 -161,015,423 -91% 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 225,472,618 +72,758,442 +48% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 176,803,587 +24,949,411 +16% 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 11,750,881 -138,334,154 -92% 31 Dec 2013 10-K 26 Mar 2015 2014 FY
Q3 2013 176,243,587 +26,158,552 +17% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 152,714,176 +24,127,532 +19% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 151,854,176 +25,117,018 +20% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 150,085,035 +23,640,726 +19% 31 Dec 2012 10-K 27 Mar 2014 2013 FY
Q3 2012 150,085,035 +24,465,726 +19% 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 128,586,644 +6,012,716 +4.9% 30 Jun 2012 10-Q/A 29 Aug 2012 2012 Q2
Q1 2012 126,737,158 31 Mar 2012 10-Q 11 May 2012 2012 Q1
Q4 2011 126,444,309 +30,611,331 +32% 31 Dec 2011 10-K 14 Mar 2013 2012 FY
Q3 2011 125,619,309 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 122,573,928 30 Jun 2011 10-Q/A 07 Sep 2011 2011 Q2
Q4 2010 95,832,978 31 Dec 2010 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.